News & Updates

Roflumilast serves up weight-loss benefit for patients with psoriasis
Roflumilast serves up weight-loss benefit for patients with psoriasis
20 Oct 2023
ALA-PDT on par with minocycline for moderate-to-severe rosacea
ALA-PDT on par with minocycline for moderate-to-severe rosacea
08 Oct 2023

Patients with moderate-to-severe rosacea may benefit from treatment with 5-aminolevulinic acid photodynamic therapy (ALA-PDT), which has shown its efficacy and noninferiority to minocycline in a recent study.

ALA-PDT on par with minocycline for moderate-to-severe rosacea
08 Oct 2023